from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1726/-

LFCtreatmentdescriptionclass of inhibitor

-0.308

Amikacinug/mL Amikacintranslation

0.090

Cap5-10ug/mL Capreomycintranslation

-0.357

Rox10-50 ug/mL Roxithromycintranslation

0.407

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.056

Rif0.2-5ug/mL Rifampicintranscription

0.100

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.106

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.801

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.541

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.205

Clofazimine10-13 ug/mL Clofaziminerespiration

0.081

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.286

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

4.067

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.386

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.759

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.580

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.060

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.540

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.248

Nigericin50 uM Nigericinrespiration

1.034

TRC10-150 ug/mL Triclosanrespiration

0.796

TRZ10-25 ug/mL Thioridazinerespiration

0.328

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.051

menadione6-10 ug/mL Menadionerespiration

0.141

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.289

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.648

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.138

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.478

NRP_1Non-replicating persistence stage 1dosRassociated

0.197

Amp0.2mg/mL AmpicillincellWall

-0.256

Cephalexin20-100 ug/mL CephalexincellWall

0.429

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.243

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.305

EMB10-20 ug/mL EthambutolcellWall

0.383

Eta12-40 ug/mL EthionamidecellWall

-0.550

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.228

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.194

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.087

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.387

BZA0.12 mg/mL BenzamidearomaticAmides

0.409

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.353

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.473

H2O24 mM hydrogen peroxideDNAdamaging

-0.180

Levo10 ug/mL LevofloxacinDNAdamaging

0.216

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.384

Novobiocin10 ug/mL NovobiocinDNAdamaging

-1.006

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.186

UVUV-irradiationDNAdamaging

-0.200

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.097

Antimycin12.5-50 ug/mL Antimycin A?

-1.259

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.210

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.788

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.738

PA8240.2-2 ug/mL PA-824?

-0.467

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.107

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.402

Verapamil50 uM Verapamil?

0.347

mercaptoethanol2 mM 2-Mercaptoethanol?

0.608

methoxatin10-20 ug/mL Methoxatin?